PDCD1 and neoplasm: Immune checkpoint inhibitors (ICIs) are a class of drugs targeting programmed cell death 1 (PD-1) and programmed death-ligand 1 (PD-L1), thus regulating the immune checkpoints and enhancing the function of the immune system for tumor suppression [1].